Breast cancer
Conditions
Interventions
Gold Standard:Pathologically confirmed diagnosis based on biopsy evidence obtained via puncture or surgery.
Index test:A prediction model for HER2 expression status in breast cancer based on ultrasound radiomic features (including the radiomic signature and the clinical-radiomic combined nomogram).
Sponsors
The Affiliated Hospital of Southwest Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Patients who were pathologically diagnosed with breast cancer by surgery or biopsy in our hospital from January 2023 to September 2025; 2.Patients who underwent breast ultrasound examination within two weeks before surgery in our hospital, with images of adequate quality; 3.Patients with complete clinical and pathological data, including definitive HER2 status (IHC/FISH).
Exclusion criteria
Exclusion criteria: 1.Patients who had received neoadjuvant therapy; 2.Patients who had undergone radiotherapy, hormonal therapy, or chemotherapy, as these treatments may alter the growth and blood supply of breast lesions; 3.Patients with incomplete clinical or pathological data; 4.Patients with poor-quality ultrasound images.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Human Epidermal Growth Factor Receptor 2, HER2; | — |
Countries
China
Contacts
Public ContactBin Liang
The Affiliated Hospital of Southwest Medical University
Outcome results
None listed